14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 69 days ( 0 % )
Last Price $28.24 0 %
High/ Low $28.24 - $28.24 0%
Chg 7 Days N/A $28.24 $28.24
Chg 30 Days N/A $28.24 $28.24
Chg 12 mos 3.33 % $27.33 $28.24
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 5.18 % Width: 2.06 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $29.20 - $29.81 3.42 % - 5.54 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy May 03, 2022 - 74 days
Long MA avg 12 mos Sell Apr 28, 2022 - 77 days
Short/Long MA avg 12 mos Buy Dec 30, 2021 - 159 days
Pivot Short Sell Aug 15, 2022 - 3 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Intersect ENT

Intersect ENT Intersect ENT, Inc., a commercial stage drug-device company, provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. It offers PROPEL and PROPEL mini drug releasing implants for patients undergoing sinus surgery to treat chronic sinusitis. The company is also developing RESOLVE, a steroid releasing implant for refractory disease for the treatment of patients in the physician office setting; and NOVA... XENT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT